Zipdrug is a technology company.
Zipdrug has raised $14.0M across 2 funding rounds.
Key people at Zipdrug.
Zipdrug has raised $14.0M in total across 2 funding rounds.
Key people at Zipdrug.
Zipdrug has raised $14.0M in total across 2 funding rounds.
Zipdrug's investors include Alchemist Accelerator, Alpine Meridien, Amplify.LA, Andreessen Horowitz, Asylum Ventures, AV8 Ventures, Bam Ventures, B Capital Group, Bonfire Ventures, BoxGroup, Bryant Stibel, Distributed Ventures.
Zipdrug is a healthcare technology company founded in 2015 that developed a pharmacy benefit management platform focused on medication delivery, adherence, and cost control for health plans, particularly serving Medicare Advantage, Medicaid, and commercial members.[1][2][3] It connects patients—especially seniors—with a network of independent pharmacies offering hand delivery, custom pill packaging, medication synchronization (med sync), and cheaper prescription alternatives, solving barriers like transportation, high costs, and non-adherence.[1][2][3][5] The company raised $13.42M before being acquired by IngenioRx in July 2020, after which its services integrated into IngenioRx's personalized pharmacy care offerings, operating across 24 states with partnerships covering over 5 million members.[1][2][3]
Zipdrug was founded in 2015 in New York (later based in Morristown, New Jersey) by CEO Stu Libby, emerging from an initial idea to use local couriers—like bike messengers—for rapid prescription delivery in urban areas, charging a $10 fee per delivery to reduce wait times and abandonment rates.[1][2][5] Early traction came from partnering with around 200 independent pharmacies and Medicare Advantage plans, targeting seniors overspending on meds by flagging them via health plan data and offering lower-cost generics or alternatives with home delivery.[2][5] A pivotal $2.6M seed round in 2016 fueled expansion, evolving from urban courier service to a full pharmacy benefit manager with proprietary software like Care Control for real-time patient data sharing, culminating in the 2020 IngenioRx acquisition.[1][3][5]
Zipdrug rides the digital health wave of pharmacy delivery and benefit management, capitalizing on rising medication non-adherence (affecting up to a third of prescriptions) and demand for home-based care amid aging populations and telemedicine growth.[1][5][6] Timing aligned with 2010s trends in personalized medicine and Uber-like logistics, enabling expansion in urban-to-national services just as Medicare Advantage enrollment surged past 20 million.[2][5] Market forces like payer pressure for cost control and post-COVID delivery normalization favored it, influencing the ecosystem by setting standards for tech-enabled networks—rivals like Capsule, Phil, and Blink Health followed similar models—while its IngenioRx integration amplified impact for large health plans.[1][3]
Post-acquisition, Zipdrug's platform endures within IngenioRx (now CarelonRx), likely scaling with AI-driven adherence tools and expanded telepharmacy amid prescription delivery market growth projected through 2031.[1][3] Trends like value-based care, GLP-1 drug booms, and regulatory pushes for senior access will shape it, potentially evolving into broader whole-health platforms with predictive analytics. Its influence may grow by empowering independent pharmacies as trusted payers' partners, tying back to its core mission of convenient, affordable meds that keep seniors healthier and plans leaner.[3]
Zipdrug has raised $14.0M across 2 funding rounds. Most recently, it raised $11.0M Venture Round in February 2019.
